Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells

Human Immunology

Volumn 68, Issue 7, 2007, Pages 563-571

  Kondo, Kayo ^a   Okuma, Kazu ^a   Tanaka, Reiko ^a   Zhang, Li Feng ^a   Kodama, Akira ^a   Takahashi, Yoshiaki ^b   Yamamoto, Naoki ^b   Ansari, Aftab A ^c   Tanaka, Yuetsu ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Human OX40L; IL 12; IL 4; OX40; T cells; TCR stimulation; TGF 1

Indexed keywords

CD134 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; IMMOBILIZED ANTIBODY; INTERLEUKIN 12; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; MONOCLONAL ANTIBODY OX40; PROTEIN OX40 LIGAND; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CULTURE MEDIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CYTOKINES; FLOW CYTOMETRY; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; OX40 LIGAND; RECEPTORS, OX40; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34250327453     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.03.012     Document Type: Article

References (41)

1. Weinberg A.D., Vella A.T., and Croft M. OX-40: life beyond the effector T-cell stage. Semin Immunol 10 (1998) 471
2. L and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15 (2001) 445
3. Song J., Salek-Ardakani S., Rogers P.R., Cheng M., Van Parijs L., and Croft M. The costimulation-regulated duration of PKB activation controls T-cell longevity. Nat Immunol 5 (2004) 150
4. Sugamura K., Ishii N., and Weinberg A.D. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 4 (2004) 420
5. Song J., So T., Cheng M., Tang X., and Croft M. Sustained survivin expression from OX40 costimulatory signals drives T-cell clonal expansion. Immunity 22 (2005) 621
6. Miura S., Ohtani K., Numata N., Niki M., Ohbo K., Ina Y., Gojobori T., Tanaka Y., Tozawa H., Nakamura M., and Sugamura K. Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol Cell Biol 11 (1991) 1313
7. + T cells with homology to tumor necrosis factor. J Exp Med 180 (1994) 757
8. Stuber E., Neurath M., Calderhead D., Fell H.P., and Strober W. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2 (1995) 507
9. Imura A., Hori T., Imada K., Ishikawa T., Tanaka Y., Maeda M., Imamura S., and Uchiyama T. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 183 (1996) 2185
10. Ohshima Y., Tanaka Y., Tozawa H., Takahashi Y., Maliszewski C., and Delespesse G. Expression and function of OX40 ligand on human dendritic cells. J Immunol 159 (1997) 3838
11. + T cells into high IL-4-producing effectors. Blood 92 (1998) 3338
12. Pippig S.D., Pena-Rossi C., Long J., Godfrey W.R., Fowell D.J., Reiner S.L., Birkeland M.L., Locksley R.M., Barclay A.N., and Killeen N. Robust B cell immunity but impaired T-cell proliferation in the absence of CD134 (OX40). J Immunol 163 (1999) 6520
13. Akiba H., Oshima H., Takeda K., Atsuta M., Nakano H., Nakajima A., Nohara C., Yagita H., and Okumura K. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J Immunol 162 (1999) 7058
14. Weinberg A.D., Wegmann K.W., Funatake C., and Whitham R.H. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T-cell function and amelioration of experimental allergic encephalomyelitis. J Immunol 162 (1999) 1818
15. Chen A.I., McAdam A.J., Buhlmann J.E., Scott S., Lupher Jr. M.L., Greenfield E.A., Baum P.R., Fanslow W.C., Calderhead D.M., Freeman G.J., and Sharpe A.H. Ox40-ligand has a critical costimulatory role in dendritic cell:T-cell interactions. Immunity 11 (1999) 689
16. Murata K., Ishii N., Takano H., Miura S., Ndhlovu L.C., Nose M., Noda T., and Sugamura K. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J Exp Med 191 (2000) 365
17. + intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-γ, and IL-10 regulation. J Immunol 167 (2001) 6717
18. Sato T., Ishii N., Murata K., Kikuchi K., Nakagawa S., Ndhlovu L.C., and Sugamura K. Consequences of OX40-OX40 ligand interactions in Langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice. Eur J Immunol 32 (2002) 3326
19. Fillatreau S., and Gray D. T-cell accumulation in B cell follicles is regulated by dendritic cells and is independent of B cell activation. J Exp Med 197 (2003) 195
20. Ito T., Amakawa R., Inaba M., Hori T., Ota M., Nakamura K., Takebayashi M., Miyaji M., Yoshimura T., Inaba K., and Fukuhara S. Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs. J Immunol 172 (2004) 4253
21. Zingoni A., Sornasse T., Cocks B.G., Tanaka Y., Santoni A., and Lanier L.L. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol 173 (2004) 3716
22. Kashiwakura J., Yokoi H., Saito H., and Okayama Y. T-cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol 173 (2004) 5247
23. Mestas J., Crampton S.P., Hori T., and Hughes C.C. Endothelial cell co-stimulation through OX40 augments and prolongs T-cell cytokine synthesis by stabilization of cytokine mRNA. Int Immunol 17 (2005) 737
24. Compaan D.M., and Hymowitz S.G. The crystal structure of the costimulatory OX40-OX40L complex. Structure 14 (2006) 1321
25. Takasawa N., Ishii N., Higashimura N., Murata K., Tanaka Y., Nakamura M., Sasaki T., and Sugamura K. Expression of gp34 (OX40 ligand) and OX40 on human T-cell clones. Jpn J Cancer Res 92 (2001) 377
26. Tanaka Y., Inoi T., Tozawa H., Yamamoto N., and Hinuma Y. A glycoprotein antigen detected with new monoclonal antibodies on the surface of human lymphocytes infected with human T-cell leukemia virus type-I (HTLV-I). Int J Cancer 36 (1985) 549
27. Kim M.Y., Bekiraris V., McConnell F.M., Gaspal F.M., Raykundalia C., and Lane P.J. OX40 signals during priming on dendritic cells inhibit CD4 T-cell proliferation: IL-4 switches off OX40 signals enabling rapid proliferation of Th2 effectors. J Immunol 174 (2005) 1433
28. Mendel I., and Shevach E.M. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function. Immunology 117 (2006) 196
29. Soroosh P., Ine S., Sugamura K., and Ishii N. OX40-OX40 ligand interaction through T cell-T-cell contact contributes to CD4 T-cell longevity. J Immunol 176 (2006) 5975
30. Tozawa H., Andoh S., Takayama Y., Tanaka Y., Lee B., Nakamura H., Hayami M., and Hinuma Y. Species-dependent antigenicity of the 34-kDa glycoprotein found on the membrane of various primate lymphocytes transformed by human T-cell leukemia virus type-I (HTLV-I) and simian T-cell leukemia virus (STLV-I). Int J Cancer 41 (1988) 231
31. Inudoh M., Kato N., and Tanaka Y. New monoclonal antibodies against a recombinant second envelope protein of hepatitis C virus. Microbiol Immunol 42 (1998) 875
32. Takahashi Y., Tanaka Y., Yamashita A., Koyanagi Y., Nakamura M., and Yamamoto N. OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection. J Virol 75 (2001) 6748
33. Tanaka Y., Yoshida A., Tozawa H., Shida H., Nyunoya H., and Shimotohno K. Production of a recombinant human T-cell leukemia virus type-1 trans-activator(tax1) antigen and its utilization of monoclonal antibodies against various epitopes on the tax1 antigen. Int J Cancer 48 (1991) 623
34. Kim M.Y., Anderson G., White A., Jenkinson E., Arlt W., Martensson I.L., Erlandsson L., and Lane P.J. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression. J Immunol 174 (2005) 6686
35. Baba E., Takahashi Y., Lichtenfeld J., Tanaka R., Yoshida A., Sugamura K., Yamamoto N., and Tanaka Y. Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand. J Immunol 167 (2001) 875
36. Ma B.Y., Mikolajczak S.A., Danesh A., Hosiawa K.A., Cameron C.M., Takaori-Kondo A., Uchiyama T., Kelvin D.J., and Ochi A. The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells. Blood 106 (2005) 2002
37. Ito T., Wang Y.H., Duramad O., Hori T., Delespesse G.J., Watanabe N., Qin F.X., Yao Z., Cao W., and Liu Y.J. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202 (2005) 1213
38. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., and Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231
39. Wahl S.M., Wen J., and Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol Rev 213 (2006) 213
40. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875
41. Li M.O., Sanjabi S., and Flavell R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25 (2006) 455